Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Haematologica|September 25, 2025
The sobering reality of fertility preservation in young female patients with acute leukemiaAvraham Frisch
Haematologica|October 5, 2019
How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemiaAvraham Frisch, Yishai Ofran
Blood Reviews|June 15, 2025
Novel therapies for acute myeloid leukemia. Does age still matter?Baher Krayem, Avraham Frisch, Netanel Horowitz
British Journal of Haematology|May 1, 2020
How we treat older patients with acute myeloid leukaemiaAvraham Frisch, Jacob M Rowe, Yishai Ofran
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 22, 2021
Acute and severe ribavirin-associated hyperuricemia and acute kidney injury: An underrecognized adverse effectRazan Sakran, Avraham Frisch, Adi Elias, et al.
Haematologica|March 5, 2026
Intensive induction therapy with FLAG-idarubicin-venetoclax for fit older high-risk patients with acute myeloid leukemiaAvraham Frisch, Baher Krayem, Tsila Zuckerman, et al.
Haematologica|April 23, 2026
Favorable safety and efficacy profiles of α-1-antitrypsin in steroid- and ruxolitinib-refractory acute graft-versus-host disease of the gastrointestinal tract: a retrospective, single center studyDana Yehudai-Ofir, Hazim Khatib, Ofrat Beyar-Katz, et al.
Ejhaem|August 6, 2026
Subclinical Cardiac Changes Following CPX-351 Induction in Adults with Favorable/Intermediate-Risk AMLChezi Ganzel, Avraham Frisch, Ofir Wolach, et al.
Haematologica|February 5, 2026
FLAG-IDA-Venetoclax for high-risk newly diagnosed acute myeloid leukemia: a multicenter real-world studyBaher Krayem, Avraham Frisch, Dana Yehudai-Ofir, et al.
European Journal of Haematology|December 31, 2024
Post-Relapse Outcomes of Older Patients With NPM1-Mutated AML Are Favorable With Allo Transplant in Second RemissionAvraham Frisch, Chezi Ganzel, Yishai Ofran, et al.
Pageof 3